FY23 Business Outlook
Financial performance
MICRO®
FOCUS
Notes
FY 21
Reported
FY 20
CCY
Change
%
2,900
3,063
(5.3)%
1
(1,860)
(1,876)
(0.9)%
Adjusted EBITDA
1,040
1,187 (12.4)%
35.9%
38.7% (2.8)ppt
☐
☐
Revenue decline of 5% year-on-year on a CCY
basis for FY21.
Total costs (included within Adjusted EBITDA)
reduced by 0.9%, with cost reductions used to
fund increased investment in products.
Adjusted EBITDA margin of 35.9%,
representing a decline of 2.8ppts versus FY20.
Exceptional costs in the income statement
were $247m with a cash cost of $236m.
Final Dividend of 20.3 cents has been
proposed, taking total dividend to 29.1 cents
for the year which is consistent with 5x
covered approach.
$m
Revenue
Total costs
Adj. EBITDA %
Other metrics
Reported
Reported
Exceptional costs
2
247
3,012
91.8%
Diluted adj. EPS (cents)
145
154
9 cents
Final Div. per share (cents)
20.3
15.5
31.0%
Notes
1. Included within Adjusted EBITDA.
2. FY20 exceptional costs includes impairment charge of $2.8bn.
MICRO®
FOCUSView entire presentation